deltatrials
Completed PHASE3 NCT00604357

CNI-free de Novo Protocol in Patients Undergoing Liver Transplantation With Renal Impairment

A Pilot Study to Determine the Safety and Efficacy of Induction-Therapy, De Novo MPA and Delayed mTOR-Inhibition in Liver Transplant Recipients With Impaired Renal Function. (PATRON-Study)

Sponsor: University of Regensburg

Conditions End Stage Liver Disease Impaired Renal Function
Interventions anti-CD 25 mAb, Sirolimus, MMF
Updated 5 times since 2017 Last updated: Dec 15, 2014 Started: Dec 31, 2008 Primary completion: Jul 31, 2011 Completion: Aug 31, 2012

A PHASE3 clinical study on End Stage Liver Disease and Impaired Renal Function, this trial is completed. The trial is conducted by University of Regensburg and has accumulated 5 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE3

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE3

    First recorded

Dec 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of Regensburg
Data source: University of Regensburg

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Regensburg, Germany